Thousands of Dutch patients are facing a 10-month supply gap for medically essential Bedrocan products, including varieties clinicians consider irreplaceable for children with treatment-resistant epilepsy.
Bedrocan, one of Europe’s largest and longest-running suppliers of pharmaceutical and medical cannabis, has announced plans to commercialise a new high-CBD strain of cannabis, Bedrolina.
Denmark’s medical cannabis Pilot Programme has seen patient numbers grow by more than 90% between Q2 2022 and Q2 2023.
DANISH medical cannabis operator Stenocare has published a flurry of operational updates over the past month as it hopes to raise up to DKK30m in a new rights issue.
STENOCARE has seen double digit price rises across both the Copenhagen NASDAQ and the Frankfurt Stock Exchange, jumping 17.5% and 10% respectively over the past week.
Following the completion of the Danish facility upgrade, STENOCARE has shared three video tours from inside the facility.
America’s largest weed company, Curaleaf, is expanding into Europe with a $286 million cash-and-stock acquisition of London-based EMMAC Life Sciences, a medical cannabis cultivator operating in the UK, Germany, Portugal, Spain and Italy.
